Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)

计划入组 215 人 · 首次发布于 2018 年 6 月 19 日

St. Barbara Specialised Regional Hospital No. 5: Surveillance of Healthcare-Associated Infections

计划入组 5,239 人 · 首次发布于 2018 年 9 月 27 日

Booster Vaccine for Yellow Fever

计划入组 750 人 · 首次发布于 2022 年 4 月 18 日

Quinoline Yellow WS

NO-5-ASA (NicOx)

Carthamin yellow

Center 5

United States

Xi'an No.4 Hospital

China

Ningbo No.6 Hospital

China

FDA Announces Comprehensive Ban on Petroleum-Based Food Dyes by 2026

Xcovery Partners with EVERSANA to Expand Commercial Launch of ALK-Positive NSCLC Drug Ensacove

FDA Revokes Orange B Authorization, Proposes Citrus Red No. 2 Ban in Push to Eliminate Petroleum-Based Food Dyes